Abdullah bin Duweihan Al Dhiyebi has a close relationship with “Okaz”, as he has been keen to acquire it since he was in the primary stage of his studies, indicating that what is most striking about it is its keenness to convey the truth and its comprehensiveness, as well as its keeping pace with developments that occur in society from time to time.
Read next
GLP-1 Class Therapies Expand Into Cardiovascular and Metabolic Indications
Clinical trials highlight secondary therapeutic benefits of metabolic regulators, accelerating phase-three regulatory filings.
Clinical Integration of Predictive AI Diagnostics Accelerates in Acute Care
Hospital networks deploy machine learning algorithms to reduce diagnostic latency and optimize patient triage in emergency departments.
GLP-1 Class Drugs Reshape Commercial Food and Beverage Volatility
Widespread adoption of anti-obesity pharmaceuticals is altering consumer purchasing behavior across packaged goods sectors.
Health Systems Expand Remote Patient Monitoring to Offset Labor Shortages
Hospital networks are scaling continuous biosensor monitoring to reduce hospital readmissions and manage chronic disease populations cost-effectively.
Healthcare Systems Integrate Targeted AI Models to Reduce Administrative Radiologist Burden
Hospital networks are deploying domain-specific machine learning models to automate triaging and lower diagnostic report backlog times.
Synthetic Biology Firms Scale mRNA Manufacturing for Targeted Oncology
Advanced lipid nanoparticle delivery systems enable continuous-flow synthesis of therapeutic cancer vaccines in clinical trials.